Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-12

Clinical Trial Update: Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue [NA]

View source ↗

Summary

A pivotal study evaluating the NanoKnife System for the ablation of prostate tissue has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NanoKnife System

Snippet

Sponsor: Angiodynamics, Inc. | Conditions: Prostate Cancer | NA | Status: COMPLETED